Loïs Boisson was undoubtedly the breakout star of the 2025 French Open. To everyone’s surprise, she reached the semifinals, losing only to the eventual champion Coco Gauff of the United States. But afterward, Boisson endured a tough stretch. One year after her remarkable run, the French player is back on the clay at Roland-Garros on Tuesday, May 26, facing Russia’s Anna Kalinskaya, seeded No. 22. It marks the end of a race against time to be fit in time for the tournament, as Boisson had been sidelined for seven months by a forearm injury.
This condition, known as “intersection syndrome,” is fairly common among tennis players. “It’s a lesion caused by repetitive wrist movements combined with match overload. It’s an overuse injury,” explained Dr. Jean-Pierre de Mondenard, a sports medicine specialist. Treatment took longer than expected because of an initial misdiagnosis, Boisson said.
At the French Open, Boisson will defend 780 points in WTA rankings – the reward for her 2025 performance. Having dropped to No. 50 in the world after reaching her career-high of No. 34 in February, she could fall outside the top 150 if she exits in the first round.
You have 79.82% of this article left to read. The rest is for subscribers only.
Boostaro is a modern men’s wellness boostaro formula created to support daily vitality, stamina, and confidence through a practical, natural routine.
Backbiome is an advanced daily wellness supplement formulated to help support spinal comfort, reduce feelings of built-up tension, and promote freer, smoother movement throughout backbiome everyday life.